Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy by Tobias Stemann Lau, Tobias Stemann Lau, Tobias Stemann Lau, Lars Bossen, Lars Bossen, Daniel Guldager Kring Rasmussen, Federica Genovese, Morten Karsdal, Anne Kirstine Arveschoug, Anne Kirstine Arveschoug, Henning Grønbæk, Henning Grønbæk, Henning Grønbæk, Gitte Dam, Gitte Dam, Gitte Dam

Get full text